Fundz

Mind Immune Therapeutics, Inc. reported raising $5.35 Million in an initial SEC Form D filing, from an offering of $8.88 Million

PRIVATEFeb 04, 2022$5.3M of $8.9M raised

Amount Raised

$5.35 Million

$5.35 Million sold, per SEC Form D (first sale Feb 4, 2022)

Round Type

Venture

KingstonBiotechnologyHealthcareHealth CareTherapeutics

Quick answer

MindImmune Therapeutics raised $5.35 Million in a funding round, dated February 4, 2022. MindImmune Therapeutics is based in Kingston, Rhode Island, United States.

How much did MindImmune Therapeutics raise?
MindImmune Therapeutics raised $5.35 Million in a funding round on February 4, 2022.
What does MindImmune Therapeutics do?
MindImmune Therapeutics is a venture-backed biotechnology company developing products that target the immunological drivers of neurodegenerative disease.
Where is MindImmune Therapeutics based and how big is it?
MindImmune Therapeutics is based in Kingston, Rhode Island, United States.
Who are the decision-makers at MindImmune Therapeutics?
Fundz holds 2 contacts at MindImmune Therapeutics, including the Founder and CSO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Therapeutics around the same time

Companies in the same sectors as MindImmune Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Azora Therapeutics, Inc. (DE) raised $10M on February 17, 2022.
  • Azora Therapeutics, Inc. (DE) raised $10M (Funding Round) on February 16, 2022.
  • Passage Bio raised $4M (Seed) on February 1, 2022.
  • Enliven Therapeutics raised an undisclosed amount (Funding Round) on January 19, 2022.
  • Tessera Defense & Homeland Security Inc. raised $3M (Seed) on January 4, 2022.
  • Arbutus raised $15M on December 30, 2021.

Who to call at MindImmune Therapeutics, and when

A new round usually means MindImmune Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MindImmune Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MindImmune Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MindImmune Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MindImmune Therapeutics

Location

130 FLAGG ROAD

Kingston, Rhode Island, United States

About

MindImmune Therapeutics is a venture-backed biotechnology company developing products that target the immunological drivers of neurodegenerative disease. Its lead program, MITI-101, is designed to block the harmful recruitment of peripheral immune cells into the brain in patients with Alzheimer’s disease and other neurodegenerative conditions. By targeting a key upstream mechanism of neuroinflammation, MITI-101 has the potential to deliver a first-in-class therapeutic breakthrough that improves multiple aspects of neurodegeneration.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MindImmune Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsStevin Z., Founder and CSO hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for MindImmune Therapeutics's next move

See what Strategic adds

MindImmune Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.